Tilray Brands (TLRY) EBIT Margin (2017 - 2026)
Tilray Brands' (TLRY) quarterly EBIT Margin came in at 5.84% in Q2 2026, up 63726.0% YoY from N/an in Q2 2025, and up 54.24% on a QoQ basis from 12.76% in Q1 2026.
Tilray Brands (TLRY) EBIT Margin (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of EBIT Margin data on file, last reported at 5.84% in Q2 2026.
- Quarterly EBIT Margin rose 63726.0% year-over-year to 5.84% in Q2 2026, while the trailing twelve-month figure through May 2026 was 6.88% (up 27105.0% YoY) and the FY2026 annual result came in at 6.88%, up 27105.0% from the prior year.
- EBIT Margin climbed to 5.84% in Q2 2026, from 12.76% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 1.0% in Q3 2025 to a low of 828.86% in Q1 2023.
- A 5-year average of 136.35% and a median of 19.72% in 2023 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2023 — EBIT Margin plunged 81696 bps — and 2024, when it surged 78527 bps.
- Tracing TLRY's EBIT Margin over 5 years: stood at 35.93% in 2022, then jumped by 40 bps to 21.55% in 2023, then climbed by 7 bps to 20.01% in 2024, then soared by 49 bps to 10.24% in 2025, then jumped by 43 bps to 5.84% in 2026.
- The last three EBIT Margin figures came in at 5.84% (Q2 2026), 12.76% (Q1 2026), and 10.24% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | -5.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -5.84% |
| Feb 28, 2026 | -12.76% |
| Nov 30, 2025 | -10.24% |
| Aug 31, 2025 | 1.00% |
| May 31, 2025 | -643.10% |
| Feb 28, 2025 | -409.05% |
| Nov 30, 2024 | -20.01% |
| Aug 31, 2024 | -18.28% |
| May 31, 2024 | -7.19% |
| Feb 29, 2024 | -43.59% |
| Nov 30, 2023 | -21.55% |
| Aug 31, 2023 | -19.42% |
| May 31, 2023 | -48.85% |
| Feb 28, 2023 | -828.86% |
| Nov 30, 2022 | -35.93% |
| Aug 31, 2022 | -13.82% |
| May 31, 2022 | -304.86% |
| Feb 28, 2022 | -11.90% |
| Nov 30, 2021 | -35.79% |
| Aug 31, 2021 | -41.29% |